HEADER IMMUNE SYSTEM 02-MAR-07 2UUD TITLE CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE NQ10- TITLE 2 1.12 SCFV IN COMPLEX WITH THE HAPTEN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 3 CHAIN: H, J; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 7 CHAIN: K, L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 11 CHAIN: S, T; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: BALB/C; SOURCE 6 CELL: HYBRIDOMA; SOURCE 7 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 11 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE HYBRIDOMA; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 14 ORGANISM_COMMON: MOUSE; SOURCE 15 ORGANISM_TAXID: 10090; SOURCE 16 STRAIN: BALB/C; SOURCE 17 CELL: HYBRIDOMA; SOURCE 18 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 22 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE HYBRIDOMA; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 25 ORGANISM_COMMON: MOUSE; SOURCE 26 ORGANISM_TAXID: 10090; SOURCE 27 STRAIN: BALB/C; SOURCE 28 CELL: HYBRIDOMA; SOURCE 29 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 30 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 31 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 33 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE HYBRIDOMA KEYWDS SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN KEYWDS 2 DOMAIN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR C.SCOTTI,E.GHERARDI REVDAT 3 13-DEC-23 2UUD 1 LINK REVDAT 2 24-FEB-09 2UUD 1 VERSN REVDAT 1 03-APR-07 2UUD 0 SPRSDE 03-APR-07 2UUD 2CJV JRNL AUTH C.SCOTTI,E.GHERARDI JRNL TITL STRUCTURAL BASIS OF AFFINITY MATURATION OF THE JRNL TITL 2 TEPC15-VKAPPA45.1 ANTI-2-PHENYL-5-OXAZOLONE ANTIBODIES JRNL REF J.MOL.BIOL. V. 359 1161 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16682055 JRNL DOI 10.1016/J.JMB.2006.04.036 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 809326.500 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 11404 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 574 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.99 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1026 REMARK 3 BIN R VALUE (WORKING SET) : 0.1570 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 60 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.054 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3742 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 51 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 75.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.52 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 45.34 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : GABA.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : DNA-RNA.PARAM REMARK 3 PARAMETER FILE 5 : GABA.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 5 : GABA.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FOR REFINEMENT-REBUILDING, THE PROGRAM REMARK 3 LAFIRE HAS BEEN USED, STARTING FROM THE 2CJV STRUCTURE REMARK 4 REMARK 4 2UUD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1290031548. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11988 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 65.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FLR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 7.6, 0.2 M AMMONIUM REMARK 280 SULPHATE, 30% PEG 4K, PH 7.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.47200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.82850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.47200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.82850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, S REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, T REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY S 6 REMARK 465 GLY S 7 REMARK 465 GLY S 8 REMARK 465 SER S 9 REMARK 465 GLY S 10 REMARK 465 GLY S 11 REMARK 465 GLY S 12 REMARK 465 GLY S 13 REMARK 465 SER S 14 REMARK 465 SER T 4 REMARK 465 GLY T 5 REMARK 465 GLY T 6 REMARK 465 GLY T 7 REMARK 465 GLY T 8 REMARK 465 SER T 9 REMARK 465 GLY T 10 REMARK 465 GLY T 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N GLN K 1 C ALA T 18 1.33 REMARK 500 C ALA H 113 N SER S 1 1.33 REMARK 500 N GLN L 1 C ALA S 18 1.33 REMARK 500 C ALA J 113 N SER T 1 1.33 REMARK 500 CZ PHE J 50 CZ3 TRP J 100A 2.00 REMARK 500 CE1 PHE J 50 CZ3 TRP J 100A 2.03 REMARK 500 O LEU L 33 O TYR L 49 2.11 REMARK 500 NH2 ARG K 54 OAL PHX H 1114 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY J 99 N - CA - C ANGL. DEV. = 15.1 DEGREES REMARK 500 LEU L 73 CA - CB - CG ANGL. DEV. = 16.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 7 149.67 175.67 REMARK 500 SER H 28 73.90 -67.23 REMARK 500 PHE H 29 -35.33 -25.67 REMARK 500 ASP H 31 31.60 -91.34 REMARK 500 LYS H 43 -100.50 -154.73 REMARK 500 ALA H 44 146.11 -38.31 REMARK 500 ARG H 66 -75.33 -69.86 REMARK 500 SER H 76 60.09 62.77 REMARK 500 THR H 82B 58.16 37.64 REMARK 500 LEU H 82C 170.85 -58.03 REMARK 500 GLU H 85 -5.50 -58.23 REMARK 500 TYR H 97 -9.84 -52.53 REMARK 500 PHE H 100B 68.04 -113.57 REMARK 500 SER H 112 43.69 168.01 REMARK 500 SER J 28 92.56 -61.28 REMARK 500 PHE J 29 -12.30 -49.36 REMARK 500 PRO J 41 88.18 -60.16 REMARK 500 ALA J 44 133.92 63.55 REMARK 500 LEU J 48 -94.51 -114.44 REMARK 500 PHE J 50 137.59 175.96 REMARK 500 SER J 62 -13.71 -43.72 REMARK 500 VAL J 63 -30.62 -137.68 REMARK 500 THR J 82B 75.20 46.59 REMARK 500 GLU J 85 27.92 -78.45 REMARK 500 ALA J 88 -175.04 -176.07 REMARK 500 SER K 10 109.63 -170.58 REMARK 500 SER K 20 130.61 -177.93 REMARK 500 LEU K 47 -64.20 -98.93 REMARK 500 LYS K 50 -141.36 -107.02 REMARK 500 SER K 52 12.03 -146.62 REMARK 500 ASP K 82 27.09 105.78 REMARK 500 LYS K 106A -114.23 -57.06 REMARK 500 SER L 25 -159.45 -72.54 REMARK 500 GLN L 27 157.88 178.15 REMARK 500 SER L 43 152.64 -47.72 REMARK 500 LEU L 47 -68.26 -103.71 REMARK 500 TYR L 49 -82.32 -78.36 REMARK 500 SER L 52 13.71 -148.32 REMARK 500 SER L 65 -169.34 175.39 REMARK 500 GLU L 81 2.91 -67.36 REMARK 500 LEU L 104 71.17 -117.40 REMARK 500 LYS L 106A -96.07 -91.99 REMARK 500 THR S 2 -104.84 -132.22 REMARK 500 SER S 4 23.83 47.81 REMARK 500 THR T 2 -86.43 -71.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR J 98 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHX H1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHX J1114 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5-OXAZOLONE REMARK 900 NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA REMARK 900 RELATED ID: 2DLF RELATED DB: PDB REMARK 900 HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI- REMARK 900 DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75 DBREF 2UUD H 1 113 PDB 2UUD 2UUD 1 113 DBREF 2UUD J 1 113 PDB 2UUD 2UUD 1 113 DBREF 2UUD K 1 107 PDB 2UUD 2UUD 1 107 DBREF 2UUD L 1 107 PDB 2UUD 2UUD 1 107 DBREF 2UUD S 1 18 PDB 2UUD 2UUD 1 18 DBREF 2UUD T 1 18 PDB 2UUD 2UUD 1 18 SEQRES 1 H 121 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 121 PRO GLY GLY SER LEU ARG LEU SER CYS ALA THR SER GLY SEQRES 3 H 121 PHE SER PHE THR ASP TYR TYR MET ALA TRP VAL ARG GLN SEQRES 4 H 121 PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA PHE ILE ARG SEQRES 5 H 121 ASN LYS ALA ASN GLY TYR THR THR ASP TYR SER ALA SER SEQRES 6 H 121 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASN SER GLN SEQRES 7 H 121 SER ILE LEU TYR LEU GLN MET ASN THR LEU ARG ALA GLU SEQRES 8 H 121 ASP SER ALA THR TYR TYR CYS ALA ARG GLY ASP TYR TYR SEQRES 9 H 121 GLY ALA TRP PHE ALA TYR TRP GLY GLN GLY THR LEU VAL SEQRES 10 H 121 THR VAL SER ALA SEQRES 1 J 121 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 J 121 PRO GLY GLY SER LEU ARG LEU SER CYS ALA THR SER GLY SEQRES 3 J 121 PHE SER PHE THR ASP TYR TYR MET ALA TRP VAL ARG GLN SEQRES 4 J 121 PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA PHE ILE ARG SEQRES 5 J 121 ASN LYS ALA ASN GLY TYR THR THR ASP TYR SER ALA SER SEQRES 6 J 121 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASN SER GLN SEQRES 7 J 121 SER ILE LEU TYR LEU GLN MET ASN THR LEU ARG ALA GLU SEQRES 8 J 121 ASP SER ALA THR TYR TYR CYS ALA ARG GLY ASP TYR TYR SEQRES 9 J 121 GLY ALA TRP PHE ALA TYR TRP GLY GLN GLY THR LEU VAL SEQRES 10 J 121 THR VAL SER ALA SEQRES 1 K 113 GLN VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 K 113 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 K 113 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 K 113 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 K 113 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 K 113 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 K 113 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 K 113 TYR CYS PHE GLN GLY SER HIS VAL PRO TYR THR PHE GLY SEQRES 9 K 113 GLY GLY THR LYS LEU GLU ILE LYS ARG SEQRES 1 L 113 GLN VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 113 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 113 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 L 113 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 113 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 113 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 113 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 113 TYR CYS PHE GLN GLY SER HIS VAL PRO TYR THR PHE GLY SEQRES 9 L 113 GLY GLY THR LYS LEU GLU ILE LYS ARG SEQRES 1 S 18 SER THR SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SEQRES 2 S 18 SER GLY GLY SER ALA SEQRES 1 T 18 SER THR SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SEQRES 2 T 18 SER GLY GLY SER ALA HET PHX H1114 20 HET PHX J1114 20 HETNAM PHX 4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE) HETNAM 2 PHX METHYL]AMINO}BUTANOIC ACID FORMUL 7 PHX 2(C14 H14 N2 O4) FORMUL 9 HOH *51(H2 O) HELIX 1 1 SER H 28 TYR H 32 5 5 HELIX 2 2 ASN H 52A GLY H 54 5 5 HELIX 3 3 ALA H 61 LYS H 64 5 4 HELIX 4 4 ARG H 83 SER H 87 5 5 HELIX 5 5 SER J 28 TYR J 32 5 5 HELIX 6 6 ASN J 52A GLY J 54 5 5 HELIX 7 7 ARG J 83 SER J 87 5 5 HELIX 8 8 GLU L 79 LEU L 83 5 5 SHEET 1 HA 4 LYS H 3 SER H 7 0 SHEET 2 HA 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 HA 4 ILE H 77 MET H 82 -1 O LEU H 78 N CYS H 22 SHEET 4 HA 4 THR H 68 ASP H 72 -1 O THR H 68 N GLN H 81 SHEET 1 HB 6 LEU H 11 VAL H 12 0 SHEET 2 HB 6 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 HB 6 ALA H 88 ASP H 96 -1 O ALA H 88 N VAL H 109 SHEET 4 HB 6 MET H 34 GLN H 39 -1 O ALA H 35 N ALA H 93 SHEET 5 HB 6 GLU H 46 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 HB 6 THR H 57 TYR H 59 -1 O ASP H 58 N PHE H 50 SHEET 1 HC 4 LEU H 11 VAL H 12 0 SHEET 2 HC 4 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 HC 4 ALA H 88 ASP H 96 -1 O ALA H 88 N VAL H 109 SHEET 4 HC 4 ALA H 100 TRP H 103 -1 O ALA H 100 N ASP H 96 SHEET 1 JA 4 LYS J 3 SER J 7 0 SHEET 2 JA 4 ARG J 19 SER J 25 -1 O SER J 21 N SER J 7 SHEET 3 JA 4 ILE J 77 MET J 82 -1 O LEU J 78 N CYS J 22 SHEET 4 JA 4 PHE J 67 ARG J 71 -1 O THR J 68 N GLN J 81 SHEET 1 JB 5 GLY J 10 VAL J 12 0 SHEET 2 JB 5 THR J 107 VAL J 111 1 O LEU J 108 N GLY J 10 SHEET 3 JB 5 ALA J 88 ARG J 94 -1 O ALA J 88 N VAL J 109 SHEET 4 JB 5 MET J 34 GLN J 39 -1 O ALA J 35 N ALA J 93 SHEET 5 JB 5 GLU J 46 ILE J 51 -1 O GLU J 46 N ARG J 38 SHEET 1 JC 4 GLY J 10 VAL J 12 0 SHEET 2 JC 4 THR J 107 VAL J 111 1 O LEU J 108 N GLY J 10 SHEET 3 JC 4 ALA J 88 ARG J 94 -1 O ALA J 88 N VAL J 109 SHEET 4 JC 4 TYR J 102 TRP J 103 -1 O TYR J 102 N ARG J 94 SHEET 1 KA 4 THR K 5 GLN K 6 0 SHEET 2 KA 4 SER K 20 ARG K 24 -1 O ARG K 24 N THR K 5 SHEET 3 KA 4 ASP K 70 LYS K 74 -1 O PHE K 71 N CYS K 23 SHEET 4 KA 4 GLY K 64 SER K 67 -1 O SER K 65 N THR K 72 SHEET 1 KB 5 SER K 10 PRO K 12 0 SHEET 2 KB 5 THR K 102 GLU K 105 1 O LYS K 103 N LEU K 11 SHEET 3 KB 5 GLY K 84 GLN K 90 -1 O GLY K 84 N LEU K 104 SHEET 4 KB 5 LEU K 33 GLN K 38 -1 O GLU K 34 N PHE K 89 SHEET 5 KB 5 LYS K 45 LEU K 46 -1 O LYS K 45 N LEU K 37 SHEET 1 KC 4 SER K 10 PRO K 12 0 SHEET 2 KC 4 THR K 102 GLU K 105 1 O LYS K 103 N LEU K 11 SHEET 3 KC 4 GLY K 84 GLN K 90 -1 O GLY K 84 N LEU K 104 SHEET 4 KC 4 THR K 97 PHE K 98 -1 O THR K 97 N GLN K 90 SHEET 1 LA 4 THR L 5 THR L 7 0 SHEET 2 LA 4 ALA L 19 ARG L 24 -1 O SER L 22 N THR L 7 SHEET 3 LA 4 ASP L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 LA 4 PHE L 62 SER L 65 -1 O SER L 63 N LYS L 74 SHEET 1 LB 7 LYS L 45 LEU L 46 0 SHEET 2 LB 7 LEU L 33 GLN L 38 -1 O LEU L 37 N LYS L 45 SHEET 3 LB 7 VAL L 85 GLN L 90 -1 O VAL L 85 N GLN L 38 SHEET 4 LB 7 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 5 LB 7 VAL L 85 GLN L 90 -1 O GLN L 90 N THR L 97 SHEET 6 LB 7 THR L 102 LYS L 103 -1 O THR L 102 N TYR L 86 SHEET 7 LB 7 VAL L 85 GLN L 90 -1 O TYR L 86 N THR L 102 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 2 CYS J 22 CYS J 92 1555 1555 2.02 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.05 LINK OAL PHX H1114 CZ ARG K 54 1555 1555 2.04 LINK OAL PHX H1114 NH1 ARG K 54 1555 1555 1.48 LINK OAL PHX J1114 NH2 ARG L 54 1555 1555 1.57 LINK OAP PHX J1114 NH2 ARG L 54 1555 1555 1.52 LINK CAK PHX J1114 NH2 ARG L 54 1555 1555 1.85 CISPEP 1 VAL K 94 PRO K 95 0 0.10 CISPEP 2 THR L 7 PRO L 8 0 -0.36 CISPEP 3 VAL L 94 PRO L 95 0 -0.43 SITE 1 AC1 10 ASP H 31 TYR H 32 TYR H 33 ASP H 96 SITE 2 AC1 10 TYR H 97 TYR H 98 ALA H 100 TRP H 100A SITE 3 AC1 10 HOH H2024 ARG K 54 SITE 1 AC2 10 ASP J 31 TYR J 32 TYR J 33 GLY J 95 SITE 2 AC2 10 ASP J 96 TYR J 97 ALA J 100 TRP J 100A SITE 3 AC2 10 ARG L 54 ASP L 60 CRYST1 140.944 75.657 52.854 90.00 111.33 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007095 0.000000 0.002771 0.00000 SCALE2 0.000000 0.013218 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020311 0.00000 MTRIX1 1 0.797910 -0.037040 0.601640 7.65293 1 MTRIX2 1 -0.041530 -0.999120 -0.006430 37.41358 1 MTRIX3 1 0.601350 -0.019850 -0.798740 -20.95366 1 MTRIX1 2 0.797910 -0.037040 0.601640 7.65293 1 MTRIX2 2 -0.041530 -0.999120 -0.006430 37.41358 1 MTRIX3 2 0.601350 -0.019850 -0.798740 -20.95366 1 MTRIX1 3 0.797910 -0.037040 0.601640 7.65293 1 MTRIX2 3 -0.041530 -0.999120 -0.006430 37.41358 1 MTRIX3 3 0.601350 -0.019850 -0.798740 -20.95366 1